BAUDETTE, Minn., June 30, 2020 /PRNewswire/ — ANI Pharmaceuticals, Inc. (“ANI”) (Nasdaq:ANIP) today announced the launch of Mexiletine Hydrochloride Capsules USP, 150mg, 200mg and 250mg. The current annual U.S. market for this product is approximately $16 million, according to IQVIA/IMS Health. Patrick Walsh, ANI’s Interim President and CEO, stated, “This is our sixth generic […]